Peter Riedell
Section of Hematology / Oncology
Assistant Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730

Training

DegreeYearInstitutionArea
BS2006Southern Methodist UniversityBiology
MD2010University of Tennessee College of MedicineMedicine
Residency2013Washington University St. Louis Internal Medicine
Fellowship2016Washington University St. LouisHematology/ Oncology

Academic Interests

Dr. Riedell’s primary interest is in the treatment of Hodgkin and Non-Hodgkin lymphoma. He specifically focuses on improving outcomes through the use of hematopoietic stem cell transplantation along with cellular and immunotherapies. He is active in clinical research and serves as the principal investigator on a number of clinical trials investigating novel therapeutic approaches in this patient population.


Clinical Interests

Lymphoma,Hodgkin disease,blood and bone marrow stem cell transplantation,CAR-T cell and cellular therapies


Representative Publications

  1. Riedell P, Kahl BS. How to refine treatment choice in follicular lymphoma: from low-tumor burden to high-risk follicular lymphoma. Am J Hematol Oncol. 2016;12:15-19.
  2. Riedell P, Carson KR. A drug safety evaluation of rituximab and risk of hepatitis B. Expert Opin Drug Saf. 2014 Jul;13(7):977-87.
  3. Ganti A, Liu W, Luo S, Sanfilippo KM, Roop R, Lynch R, Riedell P, O'Brian K, Colditz GA, Carson KR. Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone. Br J Haematol. 2014 Dec;167(5):699-702.
  4. O'Brian K, Luo S, Ganti A, Riedell P, Lynch RC, Roop R, Sanfilippo KM, Liu W, Colditz GA, Carson KR. Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy. Leuk Lymphoma. 2015 Jul 25:1-7.
  5. Carson KR, Riedell P, Lynch R, Nabhan C, Wildes TM, Liu W, Ganti A, Roop R, Sanfilippo KM, O'Brian K, Liu J, Bartlett NL, Cashen A, Wagner-Johnston N, Fehniger TA, Colditz GA. Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma. J Geriatr Oncol. 2015 May;6(3):211-8.



More Information

For more information about Dr. Peter Riedell publications and research collaborations , please click here